Agilent Technologies Inc. (A) Awards Grant For Translational Research In Cardiometabolic Disease
1/13/2014 10:07:54 AM
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has awarded a grant to the newly established Duke Molecular Physiology Institute. The DMPI research team is using Agilent’s integrated biology solutions to gain new insights into the metabolic and physiologic aspects of major chronic diseases such as cardiovascular disease.
Help employers find you! Check out all the jobs and post your resume.
comments powered by